Physician profile
John Patrick Reilly
NPI 1285628693
$3,615.47
in general payments reported to CMS, 2019-2025
14 companies · $257 in 2025
The $257 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,723 · 2020: $153 · 2022: $319 · 2023: $1,071 · 2024: $91.98 · 2025: $257.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $1,000 · Food and Beverage: $420.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $1,000.00 |
| Food and Beverage | $419.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $2,780.54 | 2019-2025 | Davinci Xi, Da Vinci Surgical System |
| Davol INC. | $184.46 | 2019-2024 | Phasix Mesh |
| Boston Scientific Corporation | $137.95 | 2025 | Axios |
| W. L. Gore & Associates, INC. | $109.87 | 2019-2022 | |
| Ethicon US, LLC | $86.51 | 2025 | Vistaseal, Ethicon, Evarrest |
| Covidien Lp | $84.95 | 2019 | |
| Medtronic, INC. | $69.45 | 2023-2025 | Eea, Signia |
| Supreme Orthopedic Systems, LLC | $47.79 | 2024 | |
| Innocoll Pharmaceuticals Limited | $26.74 | 2022 | |
| Tei Biosciences INC | $25.13 | 2019 | |
| Myriad Genetic Laboratories, INC. | $17.54 | 2022 | |
| Tactile Systems Technology INC | $16.49 | 2024 | Entre Plus, Flexitouch Plus |
| Integra Lifesciences Corporation | $14.08 | 2020 | |
| Misonix INC | $13.97 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Reilly listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.